Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.12e-22	114	140	20	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	6.61e-22	124	140	20	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	5.29e-21	137	140	20	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	5.08e-18	192	140	20	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP36 USP34 ADAMTS19 USP17L21 USP17L4 USP17L2 USP17L23 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	5.90e-09	654	140	21	GO:0008233
GeneOntologyMolecularFunction	vinculin binding	SORBS3 PXN UTRN	9.16e-05	13	140	3	GO:0017166
GeneOntologyMolecularFunction	histone H4 demethylase activity	JMJD6 KDM7A	4.81e-04	5	140	2	GO:0141058
GeneOntologyBiologicalProcess	protein deubiquitination	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	7.50e-21	125	136	19	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.21e-19	144	136	19	GO:0070646
GeneOntologyBiologicalProcess	post-translational protein modification	USP36 USP34 USP17L21 USP17L4 MAGEL2 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 WWP1 USP17L24 USP17L5 USP17L10 USP17L19 BCL11A BIRC6 USP17L18 USP17L17 USP17L6P USP17L3 PRKCA TNKS2 USP17L22 USP17L15	3.24e-08	1074	136	25	GO:0043687
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP36 USP34 USP17L21 USP17L4 MAGEL2 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 WWP1 USP17L24 USP17L5 USP17L10 USP17L19 BCL11A BIRC6 USP17L18 USP17L17 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15	4.25e-08	1009	136	24	GO:0070647
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	CYBB USP17L21 USP17L4 USP17L2 USP17L12 RGPD8 USP17L1 USP17L20 USP17L11 RGPD1 USP17L5 USP17L10 USP17L19 USP17L18 RASGRP1 USP17L17 GUCY2C SEC16A USP17L6P USP17L3 USP17L22 USP17L15	6.42e-05	1327	139	22	GO:0042175
GeneOntologyCellularComponent	endoplasmic reticulum membrane	CYBB USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 RASGRP1 USP17L17 GUCY2C SEC16A USP17L6P USP17L3 USP17L22 USP17L15	3.56e-04	1293	139	20	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	CYBB USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 RASGRP1 USP17L17 GUCY2C SEC16A USP17L6P USP17L3 USP17L22 USP17L15	3.78e-04	1299	139	20	GO:0098827
Domain	HABP4_PAI-RBP1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	2.63e-23	16	137	12	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	2.63e-23	16	137	12	IPR006861
Domain	UCH	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	1.37e-21	71	137	17	PF00443
Domain	USP_2	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	1.37e-21	71	137	17	PS00973
Domain	USP_3	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	1.79e-21	72	137	17	PS50235
Domain	USP_dom	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	1.79e-21	72	137	17	IPR028889
Domain	Peptidase_C19_UCH	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	1.79e-21	72	137	17	IPR001394
Domain	USP_CS	USP36 USP34 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	1.79e-20	66	137	16	IPR018200
Domain	USP_1	USP36 USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22	5.07e-20	70	137	16	PS00972
Domain	Ran_BP1	RGPD8 RGPD1 RANBP3L RGPD5	1.31e-06	12	137	4	PF00638
Domain	RANBD1	RGPD8 RGPD1 RANBP3L RGPD5	1.31e-06	12	137	4	PS50196
Domain	RanBD	RGPD8 RGPD1 RANBP3L RGPD5	1.88e-06	13	137	4	SM00160
Domain	Ran_bind_dom	RGPD8 RGPD1 RANBP3L RGPD5	1.88e-06	13	137	4	IPR000156
Domain	AMPKBI	PRKAB1 PRKAB2	5.34e-05	2	137	2	PF04739
Domain	AMPKBI	PRKAB1 PRKAB2	5.34e-05	2	137	2	SM01010
Domain	NHS	NHSL1 NHS	5.34e-05	2	137	2	PF15273
Domain	AMPK1_CBM	PRKAB1 PRKAB2	5.34e-05	2	137	2	PF16561
Domain	NHS_fam	NHSL1 NHS	5.34e-05	2	137	2	IPR024845
Domain	AMPK1_CBM	PRKAB1 PRKAB2	5.34e-05	2	137	2	IPR032640
Domain	ASC_dom	PRKAB1 PRKAB2	5.34e-05	2	137	2	IPR006828
Domain	Grip	RGPD8 RGPD1 RGPD5	6.10e-05	11	137	3	SM00755
Domain	GRIP	RGPD8 RGPD1 RGPD5	6.10e-05	11	137	3	PF01465
Domain	GRIP_dom	RGPD8 RGPD1 RGPD5	8.09e-05	12	137	3	IPR000237
Domain	GRIP	RGPD8 RGPD1 RGPD5	8.09e-05	12	137	3	PS50913
Domain	CFC	CFC1 CFC1B	1.59e-04	3	137	2	PF09443
Domain	SOHO	SORBS1 SORBS3	1.59e-04	3	137	2	PS50831
Domain	Sorb	SORBS1 SORBS3	1.59e-04	3	137	2	SM00459
Domain	Cryptic/Cripto_CFC-dom	CFC1 CFC1B	1.59e-04	3	137	2	IPR019011
Domain	Sorb	SORBS1 SORBS3	1.59e-04	3	137	2	PF02208
Domain	SoHo_dom	SORBS1 SORBS3	1.59e-04	3	137	2	IPR003127
Domain	ARM-like	RAP1GDS1 INTS7 TTI2 TOGARAM1 FRYL TEX10 RIF1 HTT ARMC8	1.73e-04	270	137	9	IPR011989
Domain	ARM-type_fold	USP34 RAP1GDS1 INTS7 TTI2 TOGARAM1 FRYL TEX10 RIF1 HTT ARMC8	2.03e-04	339	137	10	IPR016024
Domain	-	RAP1GDS1 INTS7 TOGARAM1 FRYL TEX10 RIF1 HTT ARMC8	2.36e-04	222	137	8	1.25.10.10
Domain	EGF_1	ATRN LAMC2 ITGB2 TENM2 VWDE ATRNL1 CFC1 CFC1B	5.95e-04	255	137	8	PS00022
Domain	EGF-like_CS	ATRN LAMC2 ITGB2 TENM2 VWDE ATRNL1 CFC1 CFC1B	6.92e-04	261	137	8	IPR013032
Domain	EGF_2	ATRN LAMC2 ITGB2 TENM2 VWDE ATRNL1 CFC1 CFC1B	7.64e-04	265	137	8	PS01186
Domain	Rab_bind	RGPD8 RGPD1	1.09e-03	7	137	2	PF16704
Domain	GCC2_Rab_bind	RGPD8 RGPD1	1.09e-03	7	137	2	IPR032023
Domain	EGF_LAM_2	ATRN LAMC2 ATRNL1	1.36e-03	30	137	3	PS50027
Domain	EGF_LAM_1	ATRN LAMC2 ATRNL1	1.36e-03	30	137	3	PS01248
Domain	HEAT_REPEAT	TOGARAM1 TEX10 HTT ARMC8	1.75e-03	70	137	4	PS50077
Domain	EGF	ATRN LAMC2 TENM2 VWDE ATRNL1 CFC1 CFC1B	1.76e-03	235	137	7	SM00181
Domain	HTH_MYB	SNAPC4 MYBL2	1.86e-03	9	137	2	PS51294
Domain	Myb_dom	SNAPC4 MYBL2	1.86e-03	9	137	2	IPR017930
Domain	EGF_Lam	ATRN LAMC2 ATRNL1	2.13e-03	35	137	3	SM00180
Domain	-	RGPD8 RGPD1	2.31e-03	10	137	2	1.10.220.60
Domain	EGF-like_dom	ATRN LAMC2 TENM2 VWDE ATRNL1 CFC1 CFC1B	2.44e-03	249	137	7	IPR000742
Domain	Laminin_EGF	ATRN LAMC2 ATRNL1	2.70e-03	38	137	3	IPR002049
Domain	SAM_2	ASZ1 ARAP3 TNKS2	3.85e-03	43	137	3	PF07647
Domain	PSI	ATRN ITGB2 ATRNL1	4.10e-03	44	137	3	IPR016201
Domain	TF_fork_head_CS_2	FOXD2 FOXN2 FOXJ1	4.66e-03	46	137	3	IPR030456
Domain	PSI	ATRN ITGB2 ATRNL1	4.66e-03	46	137	3	SM00423
Domain	WW	WWP1 YAP1 UTRN	4.95e-03	47	137	3	PF00397
Domain	TF_fork_head_CS_1	FOXD2 FOXN2 FOXJ1	4.95e-03	47	137	3	IPR018122
Domain	WW	WWP1 YAP1 UTRN	5.25e-03	48	137	3	SM00456
Domain	FH	FOXD2 FOXN2 FOXJ1	5.56e-03	49	137	3	SM00339
Domain	FORK_HEAD_1	FOXD2 FOXN2 FOXJ1	5.56e-03	49	137	3	PS00657
Domain	FORK_HEAD_2	FOXD2 FOXN2 FOXJ1	5.56e-03	49	137	3	PS00658
Domain	Fork_head_dom	FOXD2 FOXN2 FOXJ1	5.56e-03	49	137	3	IPR001766
Domain	FORK_HEAD_3	FOXD2 FOXN2 FOXJ1	5.56e-03	49	137	3	PS50039
Domain	Forkhead	FOXD2 FOXN2 FOXJ1	5.56e-03	49	137	3	PF00250
Domain	WW_DOMAIN_1	WWP1 YAP1 UTRN	6.22e-03	51	137	3	PS01159
Domain	WW_DOMAIN_2	WWP1 YAP1 UTRN	6.22e-03	51	137	3	PS50020
Domain	WW_dom	WWP1 YAP1 UTRN	6.56e-03	52	137	3	IPR001202
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	2.39e-23	45	108	16	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15	5.08e-15	191	108	18	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 TNKS2 USP17L22 USP17L15	6.55e-14	221	108	18	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 TNKS2 USP17L22 USP17L15	1.22e-12	262	108	18	MM15286
Pathway	REACTOME_DEUBIQUITINATION	USP34 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 TNKS2 USP17L22 USP17L15	1.13e-11	299	108	18	M27574
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 DUSP6 USP17L5 USP17L10 USP17L19 USP17L18 RASGRP1 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	3.15e-11	318	108	18	MM15278
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP34 ADAMTS19 USP17L21 USP17L4 USP17L2 USP17L12 RGPD8 USP17L1 USP17L20 USP17L11 RGPD1 USP17L5 USP17L10 USP17L19 USP17L18 SATB1 USP17L17 JMJD6 SBSPON SEC16A USP17L6P USP17L3 TNKS2 USP17L22 USP17L15	3.82e-05	1389	108	25	MM15307
Pathway	REACTOME_SMOOTH_MUSCLE_CONTRACTION	SORBS1 SORBS3 PXN ALDH2	1.42e-04	35	108	4	MM15114
Pathway	REACTOME_SMOOTH_MUSCLE_CONTRACTION	SORBS1 SORBS3 PXN ALDH2	3.19e-04	43	108	4	M1429
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	4.98e-35	21	142	16	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	4.98e-35	21	142	16	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	4.98e-35	21	142	16	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	4.98e-35	21	142	16	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	4.98e-35	21	142	16	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	4.98e-35	21	142	16	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.82e-34	22	142	16	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.78e-33	24	142	16	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	4.93e-33	25	142	16	21115691
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	9.97e-33	33	142	17	20228807
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.28e-32	26	142	16	35816173
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.99e-32	34	142	17	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	3.85e-32	35	142	17	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	3.85e-32	35	142	17	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	7.27e-32	36	142	17	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.34e-31	37	142	17	20228808
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.62e-31	29	142	16	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.09e-26	50	142	16	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	8.63e-13	10	142	6	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	3.77e-12	12	142	6	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	1.22e-11	14	142	6	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	1.08e-10	19	142	6	28067227
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	CYBB USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CD80 USP17L6P USP17L3 USP17L22 USP17L15	3.56e-10	674	142	18	37196079
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP36 USP34 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	1.58e-09	81	142	8	12838346
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 NCOA3 TSHZ3 RGPD8 CENPF RGPD1 BIRC6 ALMS1 SATB1 SEC16A PXN UTRN WDR62 MYBL2	2.10e-09	418	142	14	34709266
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	CEP85L LARP1 FRYL SORBS1 NHSL1 ZNF106 BMX ALMS1 YAP1 SEC16A FAM83G COBL NHS CEP152 CGNL1 PEAK1 UTRN WDR62	1.62e-08	861	142	18	36931259
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	RGPD1 NHSL1 ALMS1 SEC16A COBL NHS CEP152 PEAK1 UTRN WDR62	1.65e-08	209	142	10	36779422
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 WWP1 EMID1 FRYL REV3L LARS2 BIRC6 NHSL1 ARAP3 PLA2G4B SORBS3 SEC16A HELZ2 PXN COBL DENND5A SNAPC4 HTT MYBL2	1.35e-07	1105	142	19	35748872
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	6.24e-07	119	142	7	28625976
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	CENPF FRYL SORBS1 ALMS1 COBL TNKS2 RGPD5	6.60e-07	120	142	7	31413325
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYO5B TOGARAM1 SPAG9 BIRC6 ALMS1 ATRNL1 UTP4 HELZ2 CEP152 ZNF518B CGNL1 PEAK1	9.49e-07	493	142	12	15368895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	USP36 MYO5B DUSP6 FAM91A1 SPAG9 TEX10 BIRC6 NHSL1 RIF1 PTPN9 SORBS3 SEC16A CD44 PXN NHS PEAK1 UTRN	1.46e-06	1049	142	17	27880917
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L4 USP17L1 FAM91A1 KCNU1 USP17L3	1.57e-06	48	142	5	16421571
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD8 RGPD1 RGPD5	2.30e-06	7	142	3	15710750
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RUNDC3B LARP1 FRYL SORBS1 BIRC6 ALMS1 YAP1 SEC16A CEP152 UTRN WDR62	2.41e-06	446	142	11	24255178
Pubmed	Extracellular MRP8/14 is a regulator of β2 integrin-dependent neutrophil slow rolling and adhesion.	ITGB2 GLG1 CD44	3.68e-06	8	142	3	25892652
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 TOGARAM1 SPAG9 BIRC6 DSCAML1 ALMS1 SEC16A HELZ2	4.32e-06	225	142	8	12168954
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NCOA3 CENPF LARP1 RIF1 YAP1 SORBS3 SEC16A PXN FAM83G PRKCA NHS	7.55e-06	503	142	11	16964243
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	DONSON CENPF DUSP6 LARP1 LAMC2 LARS2 SEC16A HELZ2 ZNF518B	9.70e-06	332	142	9	37433992
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ATRN USP17L12 CENPF TAS1R3 TTI2 LARP1 SPAG9 REV3L BIRC6 DSCAML1 RANBP3L USP17L3 UTRN	1.10e-05	736	142	13	29676528
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	FRYL APOBEC1 SORBS1 RIF1 SIDT2 KANK1 UTP4 PXN CEP152 PEAK1 MYBL2	1.36e-05	536	142	11	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	FRYL APOBEC1 SORBS1 RIF1 SIDT2 KANK1 UTP4 PXN CEP152 PEAK1 MYBL2	1.41e-05	538	142	11	10512203
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 CENPF LARP1 FRYL SPAG9 TEX10 BIRC6 RIF1 UTP4 SEC16A HELZ2 UTRN	1.64e-05	653	142	12	22586326
Pubmed	SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in Sézary syndrome.	SATB1 SMARCB1	1.66e-05	2	142	2	29334836
Pubmed	AMPK-Regulated Astrocytic Lactate Shuttle Plays a Non-Cell-Autonomous Role in Neuronal Survival.	PRKAB1 PRKAB2	1.66e-05	2	142	2	32877674
Pubmed	MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.	YAP1 MYBL2	1.66e-05	2	142	2	33897882
Pubmed	Identification of the gene for Nance-Horan syndrome (NHS).	NHSL1 NHS	1.66e-05	2	142	2	15466011
Pubmed	AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism.	PRKAB1 PRKAB2	1.66e-05	2	142	2	26023060
Pubmed	The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer.	CFC1 CFC1B	1.66e-05	2	142	2	11174844
Pubmed	Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy.	CD44 PRKCA	1.66e-05	2	142	2	19794964
Pubmed	AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging.	PRKAB1 PRKAB2	1.66e-05	2	142	2	26039451
Pubmed	Vinexin family (SORBS) proteins regulate mechanotransduction in mesenchymal stem cells.	SORBS1 SORBS3	1.66e-05	2	142	2	30068914
Pubmed	USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP.	USP36 YAP1	1.66e-05	2	142	2	36470870
Pubmed	Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle.	PRKAB1 PRKAB2	1.66e-05	2	142	2	10544261
Pubmed	The role of AMP-activated protein kinase in the expression of the dystrophin-associated protein complex in skeletal muscle.	PRKAB1 PRKAB2	1.66e-05	2	142	2	29401588
Pubmed	Molecular mechanisms and functions of cytokine-inducible deubiquitinating enzymes.	USP36 USP17L2	1.66e-05	2	142	2	23773437
Pubmed	Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.	YAP1 CD44	1.66e-05	2	142	2	27773750
Pubmed	AMPKβ1 and AMPKβ2 define an isoform-specific gene signature in human pluripotent stem cells, differentially mediating cardiac lineage specification.	PRKAB1 PRKAB2	1.66e-05	2	142	2	33454005
Pubmed	Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.	PRKAB1 PRKAB2	1.66e-05	2	142	2	19723702
Pubmed	[Effects of protein kinase C activity on CD44 expression and subcellular distribution in human erythrocytes].	CD44 PRKCA	1.66e-05	2	142	2	19698232
Pubmed	Phosphoinositide 3-OH kinase regulates integrin-dependent processes in neutrophils by signaling through its effector ARAP3.	ITGB2 ARAP3	1.66e-05	2	142	2	23180820
Pubmed	Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration.	CYBB ITGB2	1.66e-05	2	142	2	26498406
Pubmed	Blocking AMPK β1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosis.	PRKAB1 PRKAB2	1.66e-05	2	142	2	36543129
Pubmed	Paxillin and ponsin interact in nascent costameres of muscle cells.	SORBS1 PXN	1.66e-05	2	142	2	17462669
Pubmed	The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.	YAP1 MYBL2	1.66e-05	2	142	2	31216474
Pubmed	Aberrant Kank1 expression regulates YAP to promote apoptosis and inhibit proliferation in OSCC.	KANK1 YAP1	1.66e-05	2	142	2	31338836
Pubmed	Identification of differentially expressed genes in mouse development using differential display and in situ hybridization.	CFC1 CFC1B	1.66e-05	2	142	2	11327798
Pubmed	Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis.	CFC1 CFC1B	1.66e-05	2	142	2	11024280
Pubmed	Muscle-specific AMPK β1β2-null mice display a myopathy due to loss of capillary density in nonpostural muscles.	PRKAB1 PRKAB2	1.66e-05	2	142	2	24522207
Pubmed	Genetic analysis of attractin homologs.	ATRN ATRNL1	1.66e-05	2	142	2	18064672
Pubmed	Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.	YAP1 CD44	1.66e-05	2	142	2	29649630
Pubmed	AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise.	PRKAB1 PRKAB2	1.66e-05	2	142	2	21896769
Pubmed	Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle.	PRKAB1 PRKAB2	1.66e-05	2	142	2	9575201
Pubmed	Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects.	CFC1 CFC1B	1.66e-05	2	142	2	11062482
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA3 LARP1 FAM91A1 SPAG9 ZNF106 RIF1 YAP1 SORBS3 SEC16A HELZ2 SNAPC4 WDR62 MYBL2	1.86e-05	774	142	13	15302935
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	USP34 FOXN2 RAP1GDS1 BIRC6 ZNF106 EFNA1 UTP4 NHS UTRN	1.97e-05	363	142	9	14691545
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	USP34 TSHZ3 INTS7 LARP1 TEX10 SEC16A SMARCB1 ARMC8	2.22e-05	282	142	8	23667531
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP36 USP34 FRYL RIF1 HELZ2 UTRN	3.28e-05	147	142	6	29576527
Pubmed	Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.	CENPF YAP1 MYBL2	3.59e-05	16	142	3	32469866
Pubmed	[A novel adaptor protein family regulating cytoskeletal organization and signal transduction--Vinexin, CAP/ponsin, ArgBP2].	SORBS1 SORBS3	4.95e-05	3	142	2	12510380
Pubmed	Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.	YAP1 MYBL2	4.95e-05	3	142	2	38182898
Pubmed	CD44 acts through RhoA to regulate YAP signaling.	YAP1 CD44	4.95e-05	3	142	2	25101858
Pubmed	The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration.	ITGB2 CD44	4.95e-05	3	142	2	19073595
Pubmed	Conserved regulation and role of Pitx2 in situs-specific morphogenesis of visceral organs.	CFC1 CFC1B	4.95e-05	3	142	2	16835440
Pubmed	SATB1 makes a complex with p300 and represses gp91(phox) promoter activity.	CYBB SATB1	4.95e-05	3	142	2	14605447
Pubmed	Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function.	PRKAB1 PRKAB2	4.95e-05	3	142	2	27411013
Pubmed	Phosphorylation of paxillin at threonine 538 by PKCdelta regulates LFA1-mediated adhesion of lymphoid cells.	ITGB2 PXN	4.95e-05	3	142	2	20388733
Pubmed	Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons.	PRKAB1 PRKAB2	4.95e-05	3	142	2	27467571
Pubmed	Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.	LAMC2 YAP1	4.95e-05	3	142	2	31676872
Interaction	VASP interactions	SORBS1 NHSL1 ALMS1 MICALL2 YAP1 UTP4 SEC16A PXN NHS CEP152 PEAK1 WDR62	6.96e-07	294	135	12	int:VASP
Interaction	HSPB8 interactions	CPNE2 USP34 RGPD8 ARAP3 ALMS1 SEC16A PRKCA HTT RGPD5	2.43e-06	172	135	9	int:HSPB8
Interaction	YWHAH interactions	NCOA3 CEP85L LARP1 FRYL SORBS1 NHSL1 ZNF106 KANK1 ALMS1 YAP1 SEC16A FAM83G COBL NHS CEP152 CGNL1 ALDH2 PEAK1 UTRN WDR62 HTT	1.38e-05	1102	135	21	int:YWHAH
Interaction	GSK3A interactions	RGPD1 NHSL1 KANK1 ALMS1 SEC16A PXN COBL PRKCA NHS CEP152 PEAK1 UTRN WDR62	1.48e-05	464	135	13	int:GSK3A
Interaction	CTNNA1 interactions	RAP1GDS1 CENPF ECT2L SORBS1 NHSL1 YAP1 CD44 NHS PEAK1 UTRN ARMC8	2.25e-05	347	135	11	int:CTNNA1
Interaction	VCL interactions	RAP1GDS1 SORBS1 BIRC6 ALMS1 YAP1 SORBS3 SEC16A PXN PRKCA PEAK1	4.05e-05	305	135	10	int:VCL
Cytoband	4p16.1	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P ZNF518B USP17L22 USP17L15	4.83e-23	79	142	15	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P ZNF518B USP17L22 USP17L15 HTT	1.64e-17	222	142	16	chr4p16
Cytoband	3q13.3-q21	TRH CD80	9.50e-06	2	142	2	3q13.3-q21
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	1.28e-20	86	140	16	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 PRKCA USP17L22 USP17L15	3.02e-20	112	140	17	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	3.86e-16	160	140	16	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 APOBEC1 USP17L19 USP17L18 SIDT2 EFNA1 USP17L17 USP17L6P USP17L3 ALDH2 USP17L22 UTRN USP17L15 FOXJ1	5.07e-12	647	140	22	MM981
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	NCOA3 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 DUSP6 USP17L5 USP17L10 SPAG9 USP17L19 USP17L18 USP17L17 JMJD6 USP17L6P USP17L3 PEAK1 SNAPC4 USP17L22 USP17L15 ARMC8	1.27e-08	1072	140	23	MM1031
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 DUSP6 USP17L5 USP17L10 APOBEC1 USP17L19 USP17L18 SIDT2 EFNA1 USP17L17 HELZ2 USP17L6P USP17L3 ALDH2 USP17L22 UTRN USP17L15 FOXJ1	3.38e-08	1226	140	24	MM979
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 USP17L4 USP17L2 DONSON USP17L12 USP17L1 CEP85L USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 FAM83G PRKCA USP17L22 USP17L15	6.04e-06	1198	140	20	MM1062
Coexpression	GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP	ATRN FRYL BCL11A ARAP3 CD44 HELZ2 PXN UTRN	1.22e-05	199	140	8	M5357
Coexpression	JIANG_MELANOMA_TRM4	CYBB CEP85L DUSP6 APOBEC1 CD80 CD44 ALDH2 DENND5A	1.41e-05	203	140	8	M48968
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ATRN USP34 NCOA3 CENPF WWP1 TOGARAM1 FRYL SPAG9 REV3L LARS2 RIF1 PTPN9 YAP1 PRKCA DENND5A	5.60e-05	856	140	15	M4500
Coexpression	GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP	USP34 MAGEL2 PKNOX2 IL1R2 CD44 PXN KDM7A	1.00e-04	199	140	7	M7710
Coexpression	GSE17721_LPS_VS_CPG_12H_BMDC_UP	CPNE2 NCOA3 FRYL BATF2 CD80 HELZ2 DENND5A	1.00e-04	199	140	7	M4005
Coexpression	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP	DUSP6 FAM91A1 BCL11A ITGB2 IL1R2 CD44 DENND5A	1.03e-04	200	140	7	M4545
Coexpression	GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	RAP1GDS1 SPAG9 REV3L RASGRP1 CD44 DENND5A UTRN	1.03e-04	200	140	7	M6943
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	PDSS2 DONSON MYO5B CENPF CEP85L WWP1 BIRC6 ZNF106 RIF1 KANK1 ALMS1 KDM7A ZNF518B	1.32e-05	532	123	13	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	Myeloid Cells, GN.Bl, CD11b+ Ly6-G+, Blood, avg-3	CYBB CPNE2 DUSP6 APOBEC1 BMX ARAP3 IL1R2 CD80 CD44 KDM7A ALDH2	2.65e-05	409	123	11	GSM854306_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	MAGEL2 AFF2 LARS2 NHSL1 BOD1 GLG1 CARF SORBS3 COBL KDM7A ARMC8	4.83e-05	437	123	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K2
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 DSCAML1 PLA2G4B SBSPON SCNN1B COBL CGNL1 UTRN	4.28e-09	181	134	9	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B DSCAML1 KANK1 YAP1 CD44 COBL NHS SDK1 HYDIN	8.96e-09	197	134	9	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 PLA2G4B SBSPON SCNN1B COBL CGNL1 UTRN FOXJ1	9.79e-09	199	134	9	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 DSCAML1 PLA2G4B SBSPON SCNN1B COBL CGNL1 UTRN	1.02e-08	200	134	9	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ITGB2 BMX ARAP3 IL1R2 CD44 PXN KDM7A	5.12e-08	171	134	8	ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ITGB2 BMX ARAP3 IL1R2 CD44 PXN KDM7A	5.12e-08	171	134	8	97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ATRN ITGB2 BMX IL1R2 CD44 PXN KDM7A	6.69e-08	177	134	8	065bebd22031f143e90a407f952b444a3f8818c7
ToppCell	facs-Marrow-Granulocytes-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ATRN ITGB2 BMX IL1R2 CD44 PXN KDM7A	6.69e-08	177	134	8	eb304f20aab075bd17aa3aef819386c0e1a235bd
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 DSCAML1 SBSPON SCNN1B COBL CGNL1 UTRN	6.69e-08	177	134	8	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 DSCAML1 SBSPON SCNN1B COBL CGNL1 UTRN	9.80e-08	186	134	8	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 DSCAML1 PLA2G4B SCNN1B COBL CGNL1 UTRN	1.58e-07	198	134	8	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 DSCAML1 PLA2G4B SCNN1B COBL CGNL1 UTRN	1.65e-07	199	134	8	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 DSCAML1 PLA2G4B SCNN1B COBL CGNL1 UTRN	1.65e-07	199	134	8	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GABRG1 SORBS1 TENM2 NHSL1 MICALL2 RANBP3L YAP1 CGNL1	1.71e-07	200	134	8	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GABRG1 SORBS1 TENM2 NHSL1 MICALL2 RANBP3L YAP1 CGNL1	1.71e-07	200	134	8	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GABRG1 SORBS1 TENM2 NHSL1 MICALL2 RANBP3L YAP1 CGNL1	1.71e-07	200	134	8	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GABRG1 SORBS1 TENM2 NHSL1 MICALL2 RANBP3L YAP1 CGNL1	1.71e-07	200	134	8	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GABRG1 SORBS1 TENM2 NHSL1 MICALL2 RANBP3L YAP1 CGNL1	1.71e-07	200	134	8	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	droplet-Spleen-nan-18m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 AFF2 PKNOX2 BMX ARAP3 IL1R2 DENND5A	6.42e-07	163	134	7	bc37c5d9f48b16096d5313657563f3ec84028c8c
ToppCell	facs-Marrow-Granulocytes\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB ITGB2 BMX ARAP3 IL1R2 CD44 PXN	8.86e-07	171	134	7	1701dedf0c18751db6c9fee3d93fff150ed0e17f
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 DSCAML1 SBSPON SCNN1B COBL CGNL1	1.16e-06	178	134	7	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAML1 PKNOX2 SBSPON ATRNL1 NHS SDK1 HYDIN	1.16e-06	178	134	7	544379f5a6145429762258d426b876bb36c112f5
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 DSCAML1 SBSPON SCNN1B COBL CGNL1	1.20e-06	179	134	7	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUNDC3B WWP1 FRYL BMX KANK1 EFNA1 UTRN	1.30e-06	181	134	7	4ea02344e1996f264dd5e14f3b19c8782ce41699
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 EFNA1 SBSPON SCNN1B COBL CGNL1	1.39e-06	183	134	7	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 EFNA1 SBSPON SCNN1B COBL CGNL1	1.50e-06	185	134	7	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CPNE2 ADAMTS19 RGPD1 CD44 NHS CGNL1 SDK1	1.61e-06	187	134	7	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 PLA2G4B SBSPON COBL CGNL1 UTRN	1.61e-06	187	134	7	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 MICALL2 RANBP3L YAP1 CGNL1	1.79e-06	190	134	7	b56c55f608b30f7379941ac7d5f0f5200f305fca
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRH EMID1 SORBS1 LARS2 TENM2 FAM83G ALDH2	1.85e-06	191	134	7	2f733d510a4862565a817f59829d8387d7ea26d9
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EMID1 FRYL SORBS1 LARS2 TENM2 FAM83G ALDH2	1.85e-06	191	134	7	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 MICALL2 RANBP3L YAP1 CGNL1	1.92e-06	192	134	7	43beaac1de99b9c1a6dab4a450b4e81286987b64
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CENPF REV3L ALMS1 CEP152 UTRN WDR62 FOXJ1	2.06e-06	194	134	7	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B DSCAML1 KANK1 COBL NHS CGNL1 SDK1	2.13e-06	195	134	7	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRYL REV3L RIF1 SATB1 SEC16A PRKCA TNKS2	2.13e-06	195	134	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LAMC2 EFNA1 SBSPON SCNN1B CGNL1 PEAK1 UTRN	2.20e-06	196	134	7	6731fef8c148b6681d6ed38afdf23c8213e0bbbe
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LAMC2 EFNA1 SBSPON SCNN1B CGNL1 PEAK1 UTRN	2.20e-06	196	134	7	6856317cd0cdcb88fe54b4ae905d91e13495b1c4
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIF6 PLB1 MYO5B LAMC2 COBL CGNL1 UTRN	2.28e-06	197	134	7	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRH DUSP6 EMID1 LAMC2 TENM2 SBSPON FAM83G	2.28e-06	197	134	7	f4dad4423384a2a25e064c849ffccf2811573be0
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 PLA2G4B SCNN1B COBL CGNL1 UTRN	2.35e-06	198	134	7	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	Control_saline-Epithelial_alveolar-AT_1-AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 SBSPON SCNN1B COBL UTRN FOXJ1	2.35e-06	198	134	7	9f972f217d2c39d4c0f7d0d4227d0fffe8535b9d
ToppCell	Control_saline-Epithelial_alveolar-AT_1\|Control_saline / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 SBSPON SCNN1B COBL CGNL1 UTRN	2.35e-06	198	134	7	9b161285df7a4e51618f3517cfc5b8221ba55786
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 SBSPON SCNN1B COBL UTRN FOXJ1	2.43e-06	199	134	7	8c9ec5f05b79cf5ae1bf7aade603c171fb0226a9
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	LARP1 RASGRP1 YAP1 SORBS3 DENND5A UTRN MYBL2	2.43e-06	199	134	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO5B LAMC2 PLA2G4B SCNN1B COBL CGNL1 UTRN	2.52e-06	200	134	7	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	Skin-Keratinocytes\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	IL20RB BCL11A CCL27 CD44 FAM83G COBL ALDH2	2.52e-06	200	134	7	59d72395199bc30df0e811fbc99149694e208860
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TRH CENPF LARS2 ITGB2 SATB1	7.57e-06	155	134	6	0e24e767a3895d31d34cabeaca0354aadae34e44
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TRH CENPF LARS2 ITGB2 SATB1	7.57e-06	155	134	6	f3489a548a2c0cc2d9117ff85865c6089ea0835d
ToppCell	facs-Spleen-nan-3m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 AFF2 TRH BMX ARAP3 IL1R2	7.86e-06	156	134	6	f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655
ToppCell	facs-Spleen-nan-3m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 AFF2 TRH BMX ARAP3 IL1R2	7.86e-06	156	134	6	da4f35353a84d919e683554932f110e29568df33
ToppCell	facs-Spleen-nan-3m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 AFF2 TRH BMX ARAP3 IL1R2	7.86e-06	156	134	6	f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CENPF DNAH12 ALMS1 CEP152 HYDIN WDR62	8.15e-06	157	134	6	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB TAS1R3 ITGB2 RASGRP1 IL1R2 WDR62	9.08e-06	160	134	6	741e3b3f4ec5c77752da54746451f332435226e3
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 DSCAML1 SCNN1B COBL FOXJ1	9.41e-06	161	134	6	1e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGPD8 TOGARAM1 TENM2 VWDE DNAH12 CD80	1.16e-05	167	134	6	8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAML1 SBSPON ATRNL1 NHS SDK1 HYDIN	1.20e-05	168	134	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB2 BMX ARAP3 IL1R2 CD44 PXN	1.24e-05	169	134	6	a5964aef04093b460bbe29d5e2e7389f8fd2d46f
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB2 BMX ARAP3 IL1R2 CD44 PXN	1.24e-05	169	134	6	e0076aa61b4ef3f836f5750005d0469d3982eb6d
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB2 BMX ARAP3 IL1R2 CD44 PXN	1.24e-05	169	134	6	2341eddfedaad8cee779c37bb87f7def058588ca
ToppCell	facs-Marrow-Granulocytes-18m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGB2 BMX ARAP3 IL1R2 CD44 PXN	1.24e-05	169	134	6	94871936ccfc73b56d425373b989b87c059d4493
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 BPIFC EMID1 ECT2L SBSPON PRKCA	1.46e-05	174	134	6	0fccd90ef72ec2e5eb369fe6d6d126c60886485a
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPNE2 BPIFC EMID1 ECT2L SBSPON PRKCA	1.46e-05	174	134	6	b2fc2a756f8e373ad903bd416d9de703d945fa1c
ToppCell	Control-Epithelial_alveolar-AT_1-AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 DSCAML1 SBSPON SCNN1B COBL	1.66e-05	178	134	6	1817bc520f3d23da8c0fa09bba50ae703a820cb1
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B LAMC2 SPAG9 CD44 NHS DENND5A	1.66e-05	178	134	6	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WWP1 FRYL BMX KANK1 EFNA1 UTRN	1.77e-05	180	134	6	67c5068b660cd5e727a665cefe3bd5f8ae887221
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WWP1 FRYL BMX KANK1 EFNA1 UTRN	1.89e-05	182	134	6	ebc812ed3f25839ea25f76b952c463d79a8325b1
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	WWP1 FRYL BMX KANK1 EFNA1 UTRN	1.89e-05	182	134	6	47ff6b4002a4167412c79210651316d1342503f9
ToppCell	IPF-Epithelial-ATI\|World / Disease state, Lineage and Cell class	LAMC2 EFNA1 YAP1 SCNN1B COBL CGNL1	1.95e-05	183	134	6	31fef35ecf30162662f24d335d8f0cceacc07039
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MYO5B LAMC2 EFNA1 SCNN1B COBL CGNL1	1.95e-05	183	134	6	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO5B LAMC2 PLA2G4B COBL CGNL1 UTRN	2.01e-05	184	134	6	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5B SCNN1B COBL CGNL1 PEAK1 UTRN	2.01e-05	184	134	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5B SCNN1B COBL CGNL1 PEAK1 UTRN	2.01e-05	184	134	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	15-Trachea-Epithelial-Multiciliated_precursor\|Trachea / Age, Tissue, Lineage and Cell class	MYO5B CENPF DNAH12 CEP152 WDR62 FOXJ1	2.07e-05	185	134	6	9a8b8360d99375b726ca8e3c9a3f9b08919892d7
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	AFF2 CENPF BCL11A CEP152 WDR62 MYBL2	2.07e-05	185	134	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 RANBP3L YAP1 CGNL1	2.13e-05	186	134	6	41e03be964044dae690d566bd078dab3d8045eba
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 KANK1 YAP1 PRKCA UTRN SDK1	2.13e-05	186	134	6	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B DSCAML1 COBL NHS SDK1 HYDIN	2.13e-05	186	134	6	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	MYO5B LAMC2 EFNA1 SCNN1B COBL CGNL1	2.13e-05	186	134	6	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NCOA3 KANK1 YAP1 PRKCA UTRN SDK1	2.13e-05	186	134	6	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5B KANK1 SBSPON NHS SDK1 HYDIN	2.13e-05	186	134	6	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WWP1 BMX KANK1 EFNA1 YAP1 UTRN	2.13e-05	186	134	6	5302399825f213d105ac70b91366a4513b732838
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	B3GALT2 CPNE2 RASGRP1 SIDT2 IL1R2 GLG1	2.20e-05	187	134	6	689b3cc76f1e04bd35a7d3ce19e9f08744a7835b
ToppCell	droplet-Thymus-nan-18m-Myeloid-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMC2 SORBS3 COBL CGNL1 HYDIN FOXJ1	2.20e-05	187	134	6	ed69e7cbd6fb59363b0e26f24887fc49405397ce
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	B3GALT2 CPNE2 RASGRP1 SIDT2 IL1R2 GLG1	2.20e-05	187	134	6	4527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 RANBP3L YAP1 CGNL1	2.20e-05	187	134	6	5d3d68519c8e19f10c29f9d81712125be78ca15a
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 RANBP3L YAP1 CGNL1	2.20e-05	187	134	6	5c73010fe4c85fb5cc1273f5504821229ca0cc4b
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 RANBP3L YAP1 CGNL1	2.20e-05	187	134	6	93c78fc7f126132eb84feb47be2c4e8c568b9e91
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	MYO5B LAMC2 SCNN1B COBL CGNL1 PEAK1	2.20e-05	187	134	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	WWP1 BMX EFNA1 CD44 ALDH2 UTRN	2.26e-05	188	134	6	50b27fc12347ca16bd62333baf345c83cb422a8f
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ADAMTS19 CD44 NHS CGNL1 SDK1 HYDIN	2.26e-05	188	134	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AFF2 MYO5B KANK1 NHS SDK1 HYDIN	2.33e-05	189	134	6	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 RANBP3L YAP1 CGNL1	2.40e-05	190	134	6	5c64b727669b23d2a23c8ad1d5d6caab7af37d56
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 RANBP3L YAP1 CGNL1	2.40e-05	190	134	6	3a55cc5dc2549788bfe55f649686887b21a1fdd2
ToppCell	IPF-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	MYO5B YAP1 SCNN1B COBL NHS SDK1	2.40e-05	190	134	6	c29dabf0826663b9d6df51a7af9b76592090e44c
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EMID1 NHSL1 KANK1 RANBP3L YAP1 CGNL1	2.40e-05	190	134	6	1c3d601422efa60fad8565f9ccd9032b847e4a91
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ADAMTS19 EQTN LAMC2 DNAH12	2.45e-05	56	134	4	ad76712e6a99072f9c6dab6d746db54f754e14fd
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ADAMTS19 EQTN LAMC2 DNAH12	2.45e-05	56	134	4	20a2977f41d3ecbc4fbee7ecd6dfb4b7ce0e4bb7
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TSHZ3 REV3L PKNOX2 CD44 NHS SDK1	2.47e-05	191	134	6	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	MYO5B KANK1 EFNA1 YAP1 COBL CGNL1	2.47e-05	191	134	6	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRH NHSL1 BMX KANK1 EFNA1 CGNL1	2.55e-05	192	134	6	14a816ef116aa992f86edab411f043cf7d07fe04
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP36 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	9.15e-31	46	138	18	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP36 USP17L21 PDSS2 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15	5.62e-29	69	138	19	DOID:1682 (implicated_via_orthology)
Disease	double outlet right ventricle (implicated_via_orthology)	CFC1 CFC1B	6.49e-05	3	138	2	DOID:6406 (implicated_via_orthology)
Disease	dextro-looped transposition of the great arteries (implicated_via_orthology)	CFC1 CFC1B	1.29e-04	4	138	2	DOID:0060770 (implicated_via_orthology)
Disease	right atrial isomerism (implicated_via_orthology)	CFC1 CFC1B	1.29e-04	4	138	2	DOID:0060856 (implicated_via_orthology)
Disease	Left ventricular mass to end-diastolic volume ratio	CEP85L PXN SMARCB1	2.13e-04	25	138	3	EFO_0010556
Disease	amino acid measurement	FOXD2 GABRG1 ADAMTS19 LARP1 DNAH12 ALMS1 GUCY2C SCNN1B COBL TNKS2 HTT	3.58e-04	678	138	11	EFO_0005134
Disease	Malignant neoplasm of breast	ADAMTS19 NCOA3 KIF6 CENPF CEP85L SORBS1 BCL11A RIF1 EFNA1 ARAP3 JMJD6 YAP1 SCNN1B NHS	5.26e-04	1074	138	14	C0006142
Disease	S-6-hydroxywarfarin to S-warfarin ratio measurement	CPNE2 SPAG9 BIRC6 ATRNL1	7.88e-04	88	138	4	EFO_0803332
Disease	Diarrhea	MYO5B GUCY2C	1.16e-03	11	138	2	C0011991
Disease	visceral heterotaxy (is_implicated_in)	CFC1 CFC1B	1.39e-03	12	138	2	DOID:0050545 (is_implicated_in)
Disease	migraine disorder	CENPF SORBS1 REV3L ZNF106 KANK1 YAP1 CARF	1.50e-03	357	138	7	MONDO_0005277
Disease	alcohol and nicotine codependence	RGPD1 PKNOX2	1.64e-03	13	138	2	EFO_0004776
Disease	Alcoholic Intoxication, Chronic	GABRG1 TRH DSCAML1 PKNOX2 KANK1 ALDH2	1.68e-03	268	138	6	C0001973
Disease	heart failure	USP36 CEP85L SMARCB1 PRKCA ALDH2	1.82e-03	185	138	5	EFO_0003144
Disease	non-dense area measurement, mammographic density measurement	RGPD1 KCNU1	2.19e-03	15	138	2	EFO_0005941, EFO_0006504
Disease	Autosomal recessive primary microcephaly	CEP152 WDR62	2.19e-03	15	138	2	cv:C3711387
Disease	proprotein convertase subtilisin/kexin type 7 measurement	DSCAML1 SIDT2	2.82e-03	17	138	2	EFO_0008270
Disease	Vitiligo	CD80 CD44	2.82e-03	17	138	2	C0042900
Disease	lateral occipital cortex volume measurement	PRKCA UTRN	2.82e-03	17	138	2	EFO_0010311
Disease	obesity (implicated_via_orthology)	ALMS1 GUCY2C SEC16A ALDH2 SDK1	3.47e-03	215	138	5	DOID:9970 (implicated_via_orthology)
Disease	Microcephaly	DONSON CENPF WDR62	3.85e-03	67	138	3	C0025958
Disease	renal system measurement	MICALL2 ALDH2	3.90e-03	20	138	2	EFO_0004742
Disease	dilated cardiomyopathy	SMARCB1 PRKCA	3.90e-03	20	138	2	EFO_0000407
Disease	aggressive behaviour measurement, ADHD symptom measurement	DUSP6 BIRC6 KDM7A	4.02e-03	68	138	3	EFO_0007826, EFO_0007860
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TSHZ3 DUSP6 BCL11A REV3L BIRC6 TENM2 KCNU1 ALMS1 UTRN SDK1	4.51e-03	801	138	10	EFO_0003888, EFO_0007052, MONDO_0002491

Protein segments in the cluster

Peptide	Gene	Start	Entry
QNPSLSQWFEHQERK	CCL27	81	Q9Y4X3
TNVIKFSDPQWNHFQ	CEP152	166	O94986
WKVSHEFAINFNPTN	CPNE2	371	Q96FN4
WTTSILKAQHDDQQP	ARAP3	1316	Q8WWN8
AQHTRTWKLQTDSNS	BIRC6	1071	Q9NR09
WRSSGKNTTNHVEVN	APOBEC1	51	P41238
RNVNHTTSKISWEFP	BMX	266	P51813
QESQHLTPGFTLQKW	AFF2	391	P51816
RAVAHKATQTESQPW	RASGRP1	666	O95267
KVWNSLQLKSHSPFQ	ALMS1	2641	Q8TCU4
FNNWSTKIPLIKSHN	PRKAB2	96	O43741
WTPFSNKSLNRQLFQ	ECT2L	11	Q008S8
VATQKHRQSPLNWTS	CFC1B	41	P0CG36
GHLRVNQTFNWNTTK	CD80	221	P33681
NQTFNWNTTKQEHFP	CD80	226	P33681
RSSKSPAHWNQVVSE	PDSS2	41	Q86YH6
VATQKHRQSPLNWTS	CFC1	41	P0CG37
QKITLEWASPQNFTS	ASZ1	386	Q8WWH4
NSSKSASRHRWPTEN	RGPD5	831	Q99666
NSSKSASRHRWPTEN	RGPD8	831	O14715
SVRTSSPKHILQWQA	ADAMTS19	701	Q8TE59
WTAPEHLRQANISQK	GUCY2C	646	P25092
NKTPHTWSRENIQAL	INTS7	281	Q9NVH2
QKRQVTHFQFLSWPD	PTPN9	456	P43378
QWKFQELSQPRSHTS	SPAG9	231	O60271
QPVREDAKWTSQHSN	LARP1	1076	Q6PKG0
SWIKQFDTSRFHPQD	KDM7A	806	Q6ZMT4
QNFASSTNFPVVWHK	JMJD6	286	Q6NYC1
QTQALAWQAQKAPTH	MAGEL2	611	Q9UJ55
TWPIKIQIAFSQHSN	ATRN	1261	O75882
QLHSSWKNVPSVNRL	FAM91A1	306	Q658Y4
KQPFTSAWFLLQHAQ	BCL11A	176	Q9H165
FHKQQTQSVWGTRQS	CARF	236	Q8N187
FSDLNTQTNWTKSLP	NHSL1	186	Q5SYE7
WTPSASRTQQARNKF	MICALL2	406	Q8IY33
LQRHFTNWTKPTSPT	PEAK1	886	Q9H792
TTFVQQRSLHQSWEK	FAM218A	66	Q96MZ4
QTLAEWNSSPISHQF	FRYL	766	O94915
SNPWHSSYVQARNQI	DNAH12	186	Q6ZR08
TKPFLQTSDSQHEWS	KIF6	706	Q6ZMV9
NTLQHEWFRVSSQKS	KANK1	1116	Q14678
TNSLSFPKQIAWNQS	KCNU1	1096	A8MYU2
TVKNSSSPVWNQSFH	PLA2G4B	51	P0C869
TSAWSILKHPFNRNS	IL20RB	121	Q6UXL0
SVLKPTNETLNFWTH	PAQR9	76	Q6ZVX9
LDQWQPSSSRFIHQQ	PXN	66	P49023
QWNNDNPLFKSATTT	ITGB2	746	P05107
HSSLRNIWKETVPQT	B3GALT2	76	O43825
DVTRVCPKHTWSNNL	GLG1	121	Q92896
QQLRTSFQDHAVWKP	ARMC8	416	Q8IUR7
WAEVQQTPKRHSLSS	HTT	1851	P42858
LSNRTNQTWNLHPIF	HYDIN	4651	Q4G0P3
SSKQQPSFHVWEGLN	BPIFC	481	Q8NFQ6
VFSWQQEKTPSHLSS	CENPF	216	P49454
TPRAFDHTKQNQDWT	CD44	311	P16070
RNSRKSDAHWITTPN	GABRG1	151	Q8N1C3
HTVFWNSSNPKFRNE	EFNA1	21	P20827
NHQPSESNWLKTLTE	CGNL1	166	Q0VF96
WDFKQSTRNISPTIN	DSCAML1	931	Q8TD84
QSREHKPALSAATWQ	BATF2	236	Q8N1L9
NFVSTHLDKQEWNPT	BOD1	91	Q96IK1
SNDKNAALAPTSWHQ	COBL	676	O75128
SVFQRVLSWIPSNNH	RAP1GDS1	316	P52306
ADPTWQNSIRHNLSL	FOXJ1	161	Q92949
NSKSISNWTFIPDRN	ADGRF2	246	Q8IZF7
NESLWQATTVPSNHR	CEP85L	36	Q5SZL2
FSWPIKIQIAFSQHN	ATRNL1	1211	Q5VV63
SNLSPSVIAQTNWKF	DENND5A	736	Q6IQ26
WDNEFKTIASQHPNT	CYBB	516	P04839
TSSQPFTWADHLKAQ	DONSON	166	Q9NYP3
TAPTGWKNSVRHNLS	FOXN2	151	P32314
HQQTWKNSAAFSPQK	GPR156	571	Q8NFN8
SPAKLQWSQRHQDVF	LAMC2	226	Q13753
LLSNTFTETNNHWPQ	EMID1	276	Q96A84
HKNIQRSTPNVPAFW	EQTN	121	Q9NQ60
LQHLSVSWEASRTPQ	HELZ2	1966	Q9BYK8
KQIPISDHWSQNLSQ	DUSP6	256	Q16828
ELSENNSPWKVHLSN	SDK1	706	Q7Z5N4
ATRNLNFSIWNHTPL	SCNN1B	136	P51168
KSQHRPTQRFWPNSI	PKNOX2	366	Q96KN3
NSSKSASRHRWPTEN	RGPD1	816	P0DJD0
SAQHQLWKQSQDSRP	FAM83G	456	A6ND36
EKFPAWQNSIRHNLS	FOXD2	166	O60548
SRQELTAHLTNQWPS	RUNDC3B	346	Q96NL0
NSSEKQWVRTKPFQH	UTP4	271	Q969X6
SQHFLSTSVQLPWQR	UTRN	2806	P46939
STSVQLPWQRSISHN	UTRN	2811	P46939
STWQKTPAESREHNR	SIDT2	771	Q8NBJ9
ERNLHPQSWTQSNIK	LARS2	141	Q15031
RSTLNPQWNESFTFK	PRKCA	216	P17252
IHNIPSTLDKQTNWS	NHS	326	Q6T4R5
IKNLQSRWRSPSHEN	RIF1	2456	Q5UIP0
QQDWKFLASHFPNRT	MYBL2	51	P10244
VSWTNETQRQKSHTF	NCOA3	181	Q9Y6Q9
QHKRRSWSISLPSNN	SHLD3	126	Q6ZNX1
KRNSQWVPTLPNSSH	SMARCB1	126	Q12824
FWRSQIHISQPQFLK	TENM2	466	Q9NT68
WKASNSVPTSVHQLR	PLB1	1076	Q6P1J6
VSPRINLTWHKNDSA	IL1R2	61	P27930
PEQWSHTTVRNALKD	SATB1	181	Q01826
SFNNWSKLPLTRSHN	PRKAB1	96	Q9Y478
INNEWHDAVSRKTFP	ALDH2	41	P05091
EWQFNHFSKLTSSRP	USP17L3	11	A6NCW0
KISRFTWSFLENNQP	VWDE	1081	Q8N2E2
RWHTSDNQKPVSRCS	TAS1R3	486	Q7RTX0
EWQFNHFSKLTSSRP	USP17L4	11	A6NCW7
HNQWKNSFHPLTTRS	REV3L	1741	O60673
FNKERTRQATSPHWS	SBSPON	146	Q8IVN8
SVSLSNSHEKNQSWR	SEC16A	846	O15027
NNPAIKHVFSWTLQQ	TTI2	221	Q6NXR4
VTKNGSDPSSWTHRQ	RANBP3L	446	Q86VV4
QLSDAFSSQSKRQPW	SORBS1	1106	Q9BX66
EWQFNHFSKLTSSRP	USP17L18	11	D6R9N7
EWQFNHFSKLTSSRP	USP17L5	11	A8MUK1
NHIDQTTTWQDPRKA	YAP1	191	P46937
TKNRSWVSPVHCTQE	TXLNGY	51	Q9BZA5
EWQFNHFSKLTSSRP	USP17L21	11	D6R901
ENPHATSNSIFINWK	TEX10	256	Q9NXF1
EWQFNHFSKLTSSRP	USP17L19	11	D6RCP7
STKIPASQHTQNWSA	SORBS3	91	O60504
EWQFNHFSKLTSSRP	USP17L1	11	Q7RTZ2
WQFTPLHEAASKNRV	TNKS2	276	Q9H2K2
WSNLNLNLHQPSSEK	TSHZ3	131	Q63HK5
NLDSSPDSHWQKNIF	WDR62	441	O43379
PDSHWQKNIFSNTLL	WDR62	446	O43379
EWQFNHFSKLTSSRP	USP17L12	11	C9JPN9
ASQIFQSDWLSKRQH	TRH	71	P20396
EWQFNHFSKLTSSRP	USP17L24	11	Q0WX57
RKFWQNSEHPSINKQ	SNAPC4	281	Q5SXM2
QNIQWAFKNLTPHAS	USP34	2876	Q70CQ2
EWQFNHFSKLTSSRP	USP17L6P	11	Q6QN14
QDNSVNFSNSWPLKS	TOGARAM1	841	Q9Y4F4
NHNTKTTQWEDPRTQ	WWP1	476	Q9H0M0
EWQFNHFSKLTSSRP	USP17L22	11	D6RA61
ESHINTKWSAPQQNF	ZNF559	56	Q9BR84
EWQFNHFSKLTSSRP	USP17L15	11	C9J2P7
EWQFNHFSKLTSSRP	USP17L17	11	D6RBQ6
TDHTNPNFQTLKCRW	ZNF106	1836	Q9H2Y7
EWQFNHFSKLTSSRP	USP17L23	11	D6RBM5
LQTRRNFWSVTHPAK	USP36	1101	Q9P275
EWQFNHFSKLTSSRP	USP17L2	11	Q6R6M4
EWQFNHFSKLTSSRP	USP17L20	11	D6RJB6
EWQFNHFSKLTSSRP	USP17L10	11	C9JJH3
EWQFNHFSKLTSSRP	USP17L11	11	C9JVI0
SNPRTTFQNKWSDQL	ZNF518B	246	Q9C0D4
NARSSWPNSEKHVDQ	MYO5B	1286	Q9ULV0